TotalMarketCap

Orchestra BioMed

OBIONasdaq United StatesHealth CareMedicinal Chemicals and Botanical Products

Market cap

$340.195 M

$5.66 -5.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Orchestra BioMed (OBIO) has a market capitalization of $340.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$33.5M

#2835 by revenue

Earnings

-$52.7M

Loss-making

Shares outstanding

60,105,049

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →
  1. #8Cronos GroupCRON$1.37B
  2. #9Tilray BrandsTLRY$416.0M
  3. #10Orchestra BioMedOBIO$340.2M
  4. #11SndlSNDL$330.9M
  5. #12Aurora CannabisACB$321.2M

What if Orchestra BioMed were worth as much as…

Open the what-if tool →

Gold $28.2T

$469,792.04

Per share 83,002× higher

Bitcoin $1.53T

$25,419.63

Per share 4,491× higher

Apple $5.02T

$83,450.27

Per share 14,744× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Orchestra BioMed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.